about
Polyphenol content and modulatory activities of some tropical dietary plant extracts on the oxidant activities of neutrophils and myeloperoxidaseTargeting NADPH oxidases in vascular pharmacologyGATA binding protein 3 is correlated with leptin regulation of PPARγ1 in hepatic stellate cellsThe quest for selective nox inhibitors and therapeutics: challenges, triumphs and pitfallsNADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agentsThe Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferationDiabetes alters activation and repression of pro- and anti-inflammatory signaling pathways in the vasculature.Diapocynin, a dimer of the NADPH oxidase inhibitor apocynin, reduces ROS production and prevents force loss in eccentrically contracting dystrophic muscleRedox-based therapeutics in neurodegenerative disease.NADPH oxidase-2: linking glucose, acidosis, and excitotoxicity in stroke.Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade.Upstream regulators and downstream effectors of NADPH oxidases as novel therapeutic targets for diabetic kidney disease.Antioxidant and antiradical activities of Manihot esculenta Crantz (Euphorbiaceae) leaves and other selected tropical green vegetables investigated on lipoperoxidation and phorbol-12-myristate-13-acetate (PMA) activated monocytes.Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stressNOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress.Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.Effects of iodonium-class flavin dehydrogenase inhibitors on growth, reactive oxygen production, cell cycle progression, NADPH oxidase 1 levels, and gene expression in human colon cancer cells and xenografts.Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical researchCML/RAGE signal induces calcification cascade in diabetesReactive oxygen species and endothelial function--role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases.Strategies for identifying synthetic peptides to act as inhibitors of NADPH oxidases, or "all that you did and did not want to know about Nox inhibitory peptides".Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies.Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies.Nox4 and diabetic nephropathy: with a friend like this, who needs enemies?Role of the Rho GTPase Rac in the activation of the phagocyte NADPH oxidase: outsourcing a key task.Advances and strategies in NADPH oxidase inhibitors and activators patents.Role of cellular senescence and NOX4-mediated oxidative stress in systemic sclerosis pathogenesis.Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.NADPH Oxidase as a Therapeutic Target for Neuroprotection against Ischaemic Stroke: Future Perspectives.NDS27 combines the effect of curcumin lysinate and hydroxypropyl-β-cyclodextrin to inhibit equine PKCδ and NADPH oxidase involved in the oxidative burst of neutrophils.The Future Challenge of Reactive Oxygen Species (ROS) in Hypertension: From Bench to Bed Side.Biphasic augmentation of alpha-adrenergic contraction by plumbagin in rat systemic arteries.Oxidative stress caused by activation of NADPH oxidase 4 promotes contrast-induced acute kidney injury.Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4.
P2860
Q24599437-D0AE7851-C5ED-4AEF-A9A7-7A329D5A49CBQ26863500-7BFA4C03-514E-478E-87E5-290052159054Q29048609-FC7517B6-2046-44FA-AAB8-D761D49C22A5Q33632757-7C2E762F-222F-4F1F-96D1-E518AA7F1AF4Q33705075-04558DE1-3D09-4043-8D04-C16D64B71676Q34294854-DE247AA8-21C4-4D75-808A-EA457577ECD9Q34350546-9BA008D2-4928-439C-ADF6-99DD6C6FD095Q34444163-315F12A7-61EB-44F5-B71D-682A0068A3E7Q34535918-6E613E6F-1019-4CFA-B6FD-7C5DC40EBA3CQ34802636-60FE0133-6F15-4503-A39E-E7BFFD47984CQ35416073-CCBDFE7F-6C01-4C0E-9D75-FD0F5803774BQ35450699-18AB9A43-FBAF-4F9B-9220-44EF0BA4903EQ35671177-DA24E1D4-1D74-4E20-9133-75337712784EQ35955745-BA72DC8F-EF5B-4E11-AB76-38A97DEDF5F0Q35985407-6EED39C4-F4C8-4F2C-B899-3B28FCA0A082Q36646486-E0B7595C-E836-44CA-BB42-3718D90A9C0EQ36674761-58849688-52AF-496C-9525-25C8615E84E3Q37433974-51EDEA7A-B2D6-4F6D-A1E3-DEF58955C7BCQ37539750-03A058D9-49DB-4F45-9675-A6D5A29D59F6Q37924981-DD16BBD8-346C-45D1-B5AE-93A6D0B91E29Q38007895-F9FA3713-E8DB-4876-97DA-B6A8179B05D1Q38019841-B44BB0F3-F40A-4A4E-81BC-0D4252E1D93CQ38019997-389693E8-F1C6-4C38-A05E-49FF5C4843FAQ38092960-FA64E2DA-10EC-4091-88CF-CF925313B9C6Q38193605-5771922B-7806-490D-BB35-B344CE17FC3BQ38257747-A2083A58-5549-43CA-8FF6-38B84C932772Q38283226-4C06A217-5F9B-4F8B-B08F-53E031F38C31Q38649653-EBC8C509-68B2-40C4-AD54-CC66632BC850Q39496194-0CDADA17-C168-4F88-AF26-B0BBE07C364EQ41606967-F6A462AE-9E11-4ECF-AE7F-88693E099500Q41660449-A5CFA517-38DF-4AC3-9EC4-222686EC9646Q47102181-1ED3E788-B46F-479C-B9E3-56F72DC84076Q48252777-AA17D8F3-0318-4A28-8C5D-90F4BF1DDAE7Q50092600-282FE611-A8DA-4439-A1E8-8D711067C0E7
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NADPH oxidase inhibitors: a patent review.
@en
NADPH oxidase inhibitors: a patent review.
@nl
type
label
NADPH oxidase inhibitors: a patent review.
@en
NADPH oxidase inhibitors: a patent review.
@nl
prefLabel
NADPH oxidase inhibitors: a patent review.
@en
NADPH oxidase inhibitors: a patent review.
@nl
P2093
P2860
P1476
NADPH oxidase inhibitors: a patent review.
@en
P2093
Byeong-Seon Jeong
Byung Chul Park
Eung Seok Lee
Ganesh Prasad Neupane
Jung-Ae Kim
Pritam Thapa
P2860
P304
P356
10.1517/13543776.2011.584870
P407
P577
2011-05-10T00:00:00Z